A special capsule that shields transplanted insulin-producing cells from a recipient’s immune system represents a cost-effective improvement in treatment for diabetes patients. The biomaterials developed and put through preclinical trials by an EU-funded project could also have other applications, such as repairing organs.

Source: Research Information Centre
Biomaterial breakthrough offers hope to diabetes patients